Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4a95c7328e9c63a07ce2de92c34d8f0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-4633 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-4625 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c7027dc47b488a6b07275bd9ea99da9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75f52854ba1056fbc05de5da76e12697 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfd6076bec76d46b529aa6dde843ce80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d53e9c60e42962ce187ad2e1c6cc7424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c27b9a025b3a2ab3ad43e6aa0721a28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c50f75115317f440ed24ea64ba0fa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7f420ac5403f0252e1e7dc88a9e828 |
publicationDate |
2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1224486-B1 |
titleOfInvention |
Use of double-quantum 1h-nmr spectroscopy for the identification of ligands interacting with target biomolecules |
abstract |
The present invention provides a rapid and efficient screening procedure for identifying and providing chemical compounds that interact with target biomolecules, for instance a therapeutic target biomolecule such as a protein, wherein the said procedure comprises generating two dimensional proton (refocused or not) double-quantum or double-quantum relaxation weighted double quantum-spectra of a mixture of compounds with and without the target biomolecule, so as to detect any differences between the spectra that identify the presence of one or more chemical compounds that bind to the target biomolecule. |
priorityDate |
1999-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |